1: With sodium hypochlorite; sodium chlorite; 2,2,6,6-tetramethyl-1-piperidinyloxy, free radical in water; acetonitrile T=20 - 35°C; 22 h; Aqueous phosphate buffer; 2: With sodium hydroxide in water; acetonitrile pH=8.0; 3: With hydrogenchloride in water pH=3.4; Product distribution / selectivity;
参考文献
TARGANTA THERAPEUTICS, INC.
Patent: US2010/113333 A1, 2010 ;
1: Et2NH / 0.5 h / Heating 2: 43.16 g / toluene-p-sulfonic acid / methanol / Heating 3: 95 percent / sodium ethoxide / ethanol / 0.5 h / 20 °C 4: 72 percent / KOH / H2O / 15 h / 20 °C 5: 99 percent / 3 h / 130 °C View Scheme
参考文献
Bulman Page, Philip C; Moore, Jonathan P.G; Mansfield, Ian; McKenzie, Michael J; Bowler, Wayne B; Gallagher, James A
Tetrahedron, 2001 , vol. 57, # 9 p. 1837 - 1847
1: 43.16 g / toluene-p-sulfonic acid / methanol / Heating 2: 95 percent / sodium ethoxide / ethanol / 0.5 h / 20 °C 3: 72 percent / KOH / H2O / 15 h / 20 °C 4: 99 percent / 3 h / 130 °C View Scheme
参考文献
Bulman Page, Philip C; Moore, Jonathan P.G; Mansfield, Ian; McKenzie, Michael J; Bowler, Wayne B; Gallagher, James A
Tetrahedron, 2001 , vol. 57, # 9 p. 1837 - 1847